Literature DB >> 31283720

Relationship of Pain Quality Descriptors and Quantitative Sensory Testing: Sickle Cell Disease.

Brenda W Dyal1, Miriam O Ezenwa, Saunjoo L Yoon, Roger B Fillingim, Yingwei Yao, Judith M Schlaeger, Marie L Suarez, Zaijie J Wang, Robert E Molokie, Diana J Wilkie.   

Abstract

BACKGROUND: Chronic pain in adults with sickle cell disease (SCD) may be the result of altered processing in the central nervous system, as indicated by quantitative sensory testing (QST). Sensory pain quality descriptors on the McGill Pain Questionnaire (MPQ) are indicators of typical or altered pain mechanisms but have not been validated with QST-derived classifications.
OBJECTIVES: The specific aim of this study was to identify the sensory pain quality descriptors that are associated with the QST-derived normal or sensitized classifications. We expected to find that sets of sensory pain quality descriptors would discriminate the classifications.
METHODS: A cross-sectional quantitative study of existing data from 186 adults of African ancestry with SCD. Variables included MPQ descriptors, patient demographic data, and QST-derived classifications.
RESULTS: The participants were classified as central sensitization (n = 33), mixed sensitization (n = 23), and normal sensation. Sensory pain quality descriptors that differed statistically between mixed sensitization and central sensation compared to normal sensitization included cold (p = .01) and spreading (p = .01). Aching (p = .01) and throbbing (p = .01) differed statistically between central sensitization compared with mixed sensitization and normal sensation. Beating (p = .01) differed statistically between mixed sensitization compared with central sensitization and normal sensation. No set of sensory pain quality descriptors differed statistically between QST classifications. DISCUSSION: Our study is the first to examine the association between MPQ sensory pain quality descriptors and QST-derived classifications in adults with SCD. Our findings provide the basis for the development of a MPQ subscale with potential as a mechanism-based screening tool for neuropathic pain.

Entities:  

Mesh:

Year:  2019        PMID: 31283720      PMCID: PMC6715502          DOI: 10.1097/NNR.0000000000000375

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  40 in total

1.  Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief.

Authors:  E Kosek; G Ordeberg
Journal:  Pain       Date:  2000-10       Impact factor: 6.961

Review 2.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

Authors:  Robert H Dworkin; Miroslav Backonja; Michael C Rowbotham; Robert R Allen; Charles R Argoff; Gary J Bennett; M Catherine Bushnell; John T Farrar; Bradley S Galer; Jennifer A Haythornthwaite; David J Hewitt; John D Loeser; Mitchell B Max; Mario Saltarelli; Kenneth E Schmader; Christoph Stein; David Thompson; Dennis C Turk; Mark S Wallace; Linda R Watkins; Sharon M Weinstein
Journal:  Arch Neurol       Date:  2003-11

3.  Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M E Shy; E M Frohman; Y T So; J C Arezzo; D R Cornblath; M J Giuliani; J C Kincaid; J L Ochoa; G J Parry; L H Weimer
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

Review 4.  Using pain quality assessment measures for selecting analgesic agents.

Authors:  Mark P Jensen
Journal:  Clin J Pain       Date:  2006-01       Impact factor: 3.442

Review 5.  Mechanisms of neuropathic pain.

Authors:  James N Campbell; Richard A Meyer
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

6.  Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease.

Authors:  R E Molokie; Z J Wang; D J Wilkie
Journal:  Med Hypotheses       Date:  2011-07-16       Impact factor: 1.538

7.  The McGill pain questionnaire: from description to measurement.

Authors:  Ronald Melzack
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

8.  Describing pain with physical disability: narrative interviews and the McGill Pain Questionnaire.

Authors:  Brian J Dudgeon; Dawn M Ehde; Diana D Cardenas; Joyce M Engel; Amy J Hoffman; Mark P Jensen
Journal:  Arch Phys Med Rehabil       Date:  2005-01       Impact factor: 3.966

9.  Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - new perspective of opioid-induced hyperalgesia.

Authors:  Kerstin Carlin Ram; Elon Eisenberg; May Haddad; Dorit Pud
Journal:  Pain       Date:  2008-06-25       Impact factor: 6.961

10.  Decreased central mu-opioid receptor availability in fibromyalgia.

Authors:  Richard E Harris; Daniel J Clauw; David J Scott; Samuel A McLean; Richard H Gracely; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2007-09-12       Impact factor: 6.167

View more
  5 in total

1.  A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Pain Pract       Date:  2019-10-18       Impact factor: 3.183

2.  Clinical efficacy and implementation issues of an electronic pain reporting device among outpatients with cancer.

Authors:  M Kay M Judge; Roberta Luedke; Brenda W Dyal; Miriam O Ezenwa; Diana J Wilkie
Journal:  Support Care Cancer       Date:  2021-03-01       Impact factor: 3.359

3.  A Stress and Pain Self-management mHealth App for Adult Outpatients With Sickle Cell Disease: Protocol for a Randomized Controlled Study.

Authors:  Miriam O Ezenwa; Yingwei Yao; Molly W Mandernach; David A Fedele; Robert J Lucero; Inge Corless; Brenda W Dyal; Mary H Belkin; Abhinav Rohatgi; Diana J Wilkie
Journal:  JMIR Res Protoc       Date:  2022-07-29

4.  Targeting TRPV1 activity via high-dose capsaicin in patients with sickle cell disease.

Authors:  Alexander K Glaros; Michael U Callaghan; Wally R Smith; Ahmar U Zaidi
Journal:  EJHaem       Date:  2022-07-19

Review 5.  Sickle cell disease chronic joint pain: Clinical assessment based on maladaptive central nervous system plasticity.

Authors:  Tiago da Silva Lopes; Samir K Ballas; Jamille Evelyn Rodrigues Souza Santana; Pedro de Melo-Carneiro; Lilian Becerra de Oliveira; Katia Nunes Sá; Larissa Conceição Dias Lopes; Wellington Dos Santos Silva; Rita Lucena; Abrahão Fontes Baptista
Journal:  Front Med (Lausanne)       Date:  2022-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.